Terkko Navigator / Haahtela, T(ari)*

Efficacy of broccoli and glucoraphanin in COVID-19: From hypothesis to proof-of-concept with three experimental clinical cases.

Spices to Control COVID-19 Symptoms: Yes, but Not Only….

Shared DNA methylation signatures in childhood allergy: the MeDALL study.

A call for urgent action to safeguard our Planet and our health in line with the Helsinki Declaration.

Treatment of allergic rhinitis during and outside the pollen season using mobile technology. A MASK study.

Nrf2-interacting nutrients and COVID-19: time for research to develop adaptation strategies.

The Helsinki Declaration 2020: Europe that protects.

The effects of climate change on respiratory allergy and asthma induced by pollen and mold allergens

Immune-microbiota interaction in Finnish and Russian Karelia young people with high and low allergy prevalence.

Long-term trends of asthma, allergic rhinitis and atopic eczema in Finnish young men: a retrospective analysis, 1926‒2017.

Cabbage and fermented vegetables: from death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID-19.

Fast and slow health crises of Homo urbanicus: loss of resilience in communicable diseases, like COVID-19, and non-communicable diseases.

ARIA-EAACI statement on Asthma and COVID-19 (June 2, 2020).

Digital transformation of health and care to sustain Planetary Health: The MASK proof-of-concept for airway diseases-POLLAR symposium under the auspices of Finland's Presidency of the EU, 2019 and MACVIA-France, Global Alliance against Chronic Respir

ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice.

Is diet partly responsible for differences in COVID-19 death rates between and within countries?

Minimising the environmental impact of inhaled therapies.

Managing Allergic Rhinitis in the Pharmacy: An ARIA Guide for Implementation in Practice.

Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement.

Why medical community should take biodiversity loss seriously?

Asthma as an example of non-communicable diseases - Let us simplify the chain of causality.

Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement.

IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper.

Contrasting microbiotas between Finnish and Estonian infants: exposure to Acinetobacter may contribute to the allergy gap.

Healthy people in healthy premises: the Finnish Indoor Air and Health Programme 2018-2028.

From ARIA guidelines to the digital transformation of health in rhinitis and asthma multimorbidity.

Helsinki by nature: The Nature Step to Respiratory Health.

School environment associates with lung function and autonomic nervous system activity in children: a cross-sectional study.

Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence.

Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases.

Mobile technology in allergic rhinitis: evolution in management or revolution in health and care?

The increase of asthma prevalence has levelled off and symptoms decreased in adults during 20 years from 1996 to 2016 in Helsinki, Finland.

ARIA masterclass 2018: From guidelines to real-life implementation.

25 years of respiratory health in Finland.

Multimorbidity in Asthma, Allergic Conditions and COPD Increase Disease Severity, Drug Use and Costs: The Finnish Pharmacy Survey.

2019 ARIA Care pathways for allergen immunotherapy.

Mobile technology offers novel insights on control and treatment of allergic rhinitis. The MASK study.

Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma.

A Biodiversity Hypothesis.

House dust microbiome and human health risks.

Birch pollen allergen immunotherapy reprograms nasal epithelial transcriptome and recovers microbial diversity.

Vilnius Declaration on chronic respiratory diseases: multisectoral care pathways embedding guided self-management, mHealth and air pollution in chronic respiratory diseases.

ARIA pharmacy 2018 "Allergic rhinitis care pathways for community pharmacy".

MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence.

ARIA Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology.

A strategy for measuring health outcomes and evaluating impacts of interventions on asthma and COPD-common chronic respiratory diseases in Global Alliance against Chronic Respiratory Diseases (GARD) countries.

Dietary patterns and respiratory health in adults from nine European countries - evidence from the GA2 LEN study.

Geolocation with respect to personal privacy for the Allergy Diary app - a MASK study.

Electronic Clinical Decision Support System for allergic rhinitis management.

The importance of the exposome and allostatic load in the planetary health paradigm.